Advertisement

Topics

CPhI Japan Company Profile

08:44 EST 20th November 2017 | BioPortfolio


News Articles [245 Associated News Articles listed on BioPortfolio]

CPhI Worldwide opens entries for pharma awards

CPhI Worldwide has announced the opening of the 2017 CPhI Pharma Awards. The CPhI Pharma Awards, acknowledged as the most prestigious in the industry, will honor companies and individuals driving the ...

The final cut — finalists for CPhI Pharma Awards unveiled

The finalists for the 2017 CPhI Pharma Awards have been revealed by the CPhI Worldwide organisers, UBM.

Floor fillers, day 2 — the latest from CPhI WW’s show floor

Welcome to our preview of exciting news and developments from day 2 of this year’s CPhI exhibition in Frankfurt.

From Russia with love? CPhI branded event will be discontinued

A joint event organised by UBM and Restec — CPhI @ IPhEB Russia — will be discontinued as a CPhI branded event next year with Restec set to organise a standalone IPhEB exhibition instead.

CPhI Worldwide report highlights unpredictability in CDMO growth

The overall findings of the CPhI Annual Report, reveal that the trend towards the integration of pharmaceutical outsourcing continues, with single source providers in terms of development increasingly...

FYI: The latest trends in APIs, FDFs and CMOs at CPhI

The pharma world has converged in Frankfurt, Germany for this yearâs CPhI Worldwide. In-Pharmatechnologist is here too to report the latest trends affecting the industry.

Floor fillers, day 1 — the latest from CPhI WW’s show floor

Here, we reveal some of the news, developments and product innovations that have been released from the show floor of day 1 of this year’s CPhI Worldwide congress in Frankfurt

Floor fillers, day 3 — the latest from CPhI WW’s show floor

As we reach the end of CPhI Worldwide, we have some more revelations and innovations that keep coming from the vast show floor here in Frankfurt Messe, enjoy and until next year tschüß!

PubMed Articles [455 Associated PubMed Articles listed on BioPortfolio]

Cumulative incidence of Kawasaki disease in Japan.

Although the nationwide surveys of Kawasaki disease (KD) in Japan have revealed the incidence rates of KD in this country, cumulative incidences, e.g., the proportion of those with a history of KD amo...

First progress report on the Japan Endoscopy Database (JED) project.

The Japan Endoscopy Database (JED) Project was initiated to develop the world's largest endoscopic database, capture the actual performance of endoscopic practice, and standardize the terminology and ...

Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.

Management of latent tuberculosis infection (LTBI) is one of the core elements of End TB Strategy. Japan is one of the few countries in which notification of LTBI is mandatory, yet so far, the data ha...

Japan Prize/Special Award in Synthetic Organic Chemistry, Japan/CNRS Medals.

Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension.

To investigate the current status of portal vein thrombosis (PVT) in Japan, the Clinical Research Committee of the Japan Society of Portal Hypertension conducted a questionnaire survey.

Clinical Trials [317 Associated Clinical Trials listed on BioPortfolio]

Clinical Characteristics and Practice Patterns of T2DM Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Appropriate use of oral antidiabetic drugs (OADs) including dose-reduction is important for patient's safety in T2DM patients with renal impairment (RI). However, there are insufficient da...

GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

The purpose of this study is to evaluate the safety and tolerability of AVE0010 once daily treatment in monotherapy in type 2 diabetes patients in Japan over 76 weeks of treatment. The pr...

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinica...

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

The purpose of this study is to compare the effects of pitavastatin and atorvastatin on coronary plaque volume in patients with acute coronary syndrome and to clarify the relationship betw...

PROMUS Element Japan Small Vessel Trial

A non-randomized, small vessel (SV) trial at approximately 15 sites in Japan to enroll 60 patients with a de novo lesion ≤28 mm in length (by visual estimate) in a native coronary arte...

Companies [423 Associated Companies listed on BioPortfolio]

CMP Media Korea Co. Ltd.

CMP Media Korea organises XpoChem and XpoPharm, as well as the XpoChem and XpoPharm conferences, and as a Korean network of CMP organising world-renowned pharmaceutical and chemical events, CPhI W...

CPhI Japan

CPhI China

CPhI India

CPhI Worldwide

More Information about "CPhI Japan" on BioPortfolio

We have published hundreds of CPhI Japan news stories on BioPortfolio along with dozens of CPhI Japan Clinical Trials and PubMed Articles about CPhI Japan for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CPhI Japan Companies in our database. You can also find out about relevant CPhI Japan Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record